Capstan Medical, which is developing heart valve implants with a robotic delivery platform, said Wednesday it has secured $110 million in new funding to advance its work leading to upcoming pivotal ...
AbbVie announced this morning it would buy clinical-stage biotech company Capstan Therapeutics for up to $2.1 billion in cash, picking up the company's in vivo CAR-T therapy candidate. San Diego-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results